SOPHiA Genetics SA

Research SOPHiA Genetics SA (SOPH) on Bullrun: market cap USD 736.36M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 736.36M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 77.27M-USD 79.00M-USD 44.51M67.4%-2.06USD 70.29MUSD 63.02MUSD 47.15M
FY2024USD 65.17M-USD 62.49M-USD 52.61M67.4%-0.95USD 80.23MUSD 30.03MUSD 96.49M
FY2023n/an/an/an/a-2.07USD 123.25MUSD 18.60MUSD 151.44M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 736.36Mn/an/an/a
20252025-12-31USD 319.83Mn/an/an/a
20242024-12-31USD 204.73Mn/an/an/a
20232023-12-29USD 306.77Mn/an/an/a
20222022-12-30USD 132.27Mn/an/an/a
20212021-12-31USD 900.39Mn/an/an/a

About SOPHiA Genetics SA

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is SOPHiA Genetics SA's market cap?

SOPHiA Genetics SA's market capitalization is USD 736.36M.

What does SOPHiA Genetics SA do?

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.